GMED
Price
$60.30
Change
+$1.50 (+2.55%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
7.94B
68 days until earnings call
SENS
Price
$0.45
Change
-$0.00 (-0.00%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
368.24M
68 days until earnings call
Interact to see
Advertisement

GMED vs SENS

Header iconGMED vs SENS Comparison
Open Charts GMED vs SENSBanner chart's image
Globus Medical
Price$60.30
Change+$1.50 (+2.55%)
Volume$15.73K
Capitalization7.94B
Senseonics Holdings
Price$0.45
Change-$0.00 (-0.00%)
Volume$47.97K
Capitalization368.24M
GMED vs SENS Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. SENS commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and SENS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (GMED: $58.80 vs. SENS: $0.45)
Brand notoriety: GMED and SENS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 93% vs. SENS: 207%
Market capitalization -- GMED: $7.94B vs. SENS: $368.24M
GMED [@Medical/Nursing Services] is valued at $7.94B. SENS’s [@Medical/Nursing Services] market capitalization is $368.24M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileSENS’s FA Score has 1 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • SENS’s FA Score: 1 green, 4 red.
According to our system of comparison, SENS is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 5 TA indicator(s) are bullish while SENS’s TA Score has 5 bullish TA indicator(s).

  • GMED’s TA Score: 5 bullish, 5 bearish.
  • SENS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SENS is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical/Nursing Services) experienced а -4.41% price change this week, while SENS (@Medical/Nursing Services) price change was -2.84% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +24.31%.

Reported Earning Dates

GMED is expected to report earnings on Nov 11, 2025.

SENS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.51% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.94B) has a higher market cap than SENS($368M). SENS YTD gains are higher at: -13.642 vs. GMED (-28.908). GMED has higher annual earnings (EBITDA): 620M vs. SENS (-59.62M). GMED has more cash in the bank: 229M vs. SENS (126M). SENS has less debt than GMED: SENS (41.2M) vs GMED (121M). GMED has higher revenues than SENS: GMED (2.63B) vs SENS (25.5M).
GMEDSENSGMED / SENS
Capitalization7.94B368M2,158%
EBITDA620M-59.62M-1,040%
Gain YTD-28.908-13.642212%
P/E Ratio22.79N/A-
Revenue2.63B25.5M10,298%
Total Cash229M126M182%
Total Debt121M41.2M294%
FUNDAMENTALS RATINGS
GMED vs SENS: Fundamental Ratings
GMED
SENS
OUTLOOK RATING
1..100
7852
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
8399
SMR RATING
1..100
7699
PRICE GROWTH RATING
1..100
5864
P/E GROWTH RATING
1..100
10028
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SENS's Valuation (58) in the Electronic Components industry is in the same range as GMED (74) in the Medical Specialties industry. This means that SENS’s stock grew similarly to GMED’s over the last 12 months.

GMED's Profit vs Risk Rating (83) in the Medical Specialties industry is in the same range as SENS (99) in the Electronic Components industry. This means that GMED’s stock grew similarly to SENS’s over the last 12 months.

GMED's SMR Rating (76) in the Medical Specialties industry is in the same range as SENS (99) in the Electronic Components industry. This means that GMED’s stock grew similarly to SENS’s over the last 12 months.

GMED's Price Growth Rating (58) in the Medical Specialties industry is in the same range as SENS (64) in the Electronic Components industry. This means that GMED’s stock grew similarly to SENS’s over the last 12 months.

SENS's P/E Growth Rating (28) in the Electronic Components industry is significantly better than the same rating for GMED (100) in the Medical Specialties industry. This means that SENS’s stock grew significantly faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSENS
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 23 days ago
65%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FVAL67.180.32
+0.47%
Fidelity Value Factor ETF
RSEE31.530.14
+0.44%
Rareview Systematic Equity ETF
VSDA53.54-0.11
-0.21%
VictoryShares Dividend Accelerator ETF
MADE28.08-0.14
-0.51%
iShares U.S. Manufacturing ETF
FTIF21.71-0.18
-0.83%
First Trust Bloomberg Infl Snstv Eq ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-1.84%
VREX - GMED
56%
Loosely correlated
-5.00%
CVRX - GMED
49%
Loosely correlated
+1.16%
CTKB - GMED
49%
Loosely correlated
-1.99%
ITGR - GMED
45%
Loosely correlated
-1.06%
TMCI - GMED
44%
Loosely correlated
+1.12%
More

SENS and

Correlation & Price change

A.I.dvisor tells us that SENS and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SENS and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SENS
1D Price
Change %
SENS100%
-0.22%
ARAY - SENS
31%
Poorly correlated
-2.01%
BMRA - SENS
28%
Poorly correlated
-5.00%
BLFS - SENS
27%
Poorly correlated
-1.18%
GMED - SENS
27%
Poorly correlated
-1.84%
OSUR - SENS
26%
Poorly correlated
-6.55%
More